Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jayant Siva

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Current Urology Reports|January 3, 2026
Cost Considerations in the Management of Nonobstructive Azoospermia in the United StatesMitsuru Komeya, Sohei Kuribayashi, Camryn Hawkins, et al.
Urology|April 16, 2026
Varicocele and Untreated Hypogonadism Synergistically Increase Prostate Cancer Risk via Testosterone Shunt Physiology and can be Ameliorated with Testosterone TherapyBryan D Naelitz, Jayant Siva, Sanjay Vallabhaneni, et al.
International Journal of Impotence Research|May 20, 2026
Attention-deficit/hyperactivity disorder stimulant use is associated with reduced semen volume in reproductive-age men: a multi-center analysisJayant Siva, Sanjay Vallabhaneni, Rishi Jonnalagadda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 25, 2025
Impact of Prolonged Warm Ischemia During Clamped Partial Nephrectomy: Comparison Between Japanese and American CohortsTakashi Ikeda, Kieran Lewis, Akira Kazama, et al.
Fertility and Sterility|May 4, 2026
Testosterone-to-Follicle Stimulating Hormone Ratio Predicts Sperm Retrieval Success in Men with Idiopathic Non-Obstructive AzoospermiaJayant Siva, Bryan Naelitz, Sanjay Vallabhaneni, et al.
BJU International|April 2, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approachJayant Siva, Can Aydogdu, Nicholas Heller, et al.
European Urology Oncology|June 11, 2026
External Validation of the International Bladder Cancer Group Intermediate-risk Non-muscle-invasive Bladder Cancer Substratification ModelJayant Siva, Rishi Jonnalagadda, Can Aydogdu, et al.
Urology|November 8, 2025
Short- and Long-Term Functional Outcomes in a Large Cohort of Partial Nephrectomy Patients Managed with Prolonged IschemiaAkira Kazama, Kieran Lewis, Carlos Munoz-Lopez, et al.
European Urology Open Science|March 2, 2026
Divergent Differentiation and Histologic Subtypes in Upper Tract Urothelial Carcinoma Demonstrate Distinct Patterns of Extraurothelial RecurrenceBetty Wang, Laura E Davis, Devika Nandwana, et al.
Urology Practice|August 22, 2025
Reply by AuthorsKieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Current Urology Reports|January 3, 2026
Cost Considerations in the Management of Nonobstructive Azoospermia in the United StatesMitsuru Komeya, Sohei Kuribayashi, Camryn Hawkins, et al.
Urology|April 16, 2026
Varicocele and Untreated Hypogonadism Synergistically Increase Prostate Cancer Risk via Testosterone Shunt Physiology and can be Ameliorated with Testosterone TherapyBryan D Naelitz, Jayant Siva, Sanjay Vallabhaneni, et al.
International Journal of Impotence Research|May 20, 2026
Attention-deficit/hyperactivity disorder stimulant use is associated with reduced semen volume in reproductive-age men: a multi-center analysisJayant Siva, Sanjay Vallabhaneni, Rishi Jonnalagadda, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|September 25, 2025
Impact of Prolonged Warm Ischemia During Clamped Partial Nephrectomy: Comparison Between Japanese and American CohortsTakashi Ikeda, Kieran Lewis, Akira Kazama, et al.
Fertility and Sterility|May 4, 2026
Testosterone-to-Follicle Stimulating Hormone Ratio Predicts Sperm Retrieval Success in Men with Idiopathic Non-Obstructive AzoospermiaJayant Siva, Bryan Naelitz, Sanjay Vallabhaneni, et al.
BJU International|April 2, 2026
Reducing complexity in International Bladder Cancer Group intermediate-risk non-muscle-invasive bladder cancer stratification: a three-factor approachJayant Siva, Can Aydogdu, Nicholas Heller, et al.
European Urology Oncology|June 11, 2026
External Validation of the International Bladder Cancer Group Intermediate-risk Non-muscle-invasive Bladder Cancer Substratification ModelJayant Siva, Rishi Jonnalagadda, Can Aydogdu, et al.
Urology|November 8, 2025
Short- and Long-Term Functional Outcomes in a Large Cohort of Partial Nephrectomy Patients Managed with Prolonged IschemiaAkira Kazama, Kieran Lewis, Carlos Munoz-Lopez, et al.
European Urology Open Science|March 2, 2026
Divergent Differentiation and Histologic Subtypes in Upper Tract Urothelial Carcinoma Demonstrate Distinct Patterns of Extraurothelial RecurrenceBetty Wang, Laura E Davis, Devika Nandwana, et al.
Urology Practice|August 22, 2025
Reply by AuthorsKieran Lewis, Jayant Siva, Angelica Bartholomew, et al.
Pageof 2